Chemoinformaics analysis of 1,4-Dimethylazulene
| Molecular Weight | 156.228 | nRot | 0 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 46 |
| Exact Molecular Weight | 156.094 | nRing | 2 |
| Solubility: LogS | -5.08 | nHRing | 0 |
| Solubility: LogP | 5.888 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 10 |
| nHA | 0 | APOL | 28.0415 |
| nHD | 0 | BPOL | 12.0385 |
| QED | 0.23 |
| Synth | 6.175 |
| Natural Product Likeliness | 1.779 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.923 |
| HIA | 0.007 |
| CACO-2 | -5.238 |
| MDCK | 0.0000256 |
| BBB | 0.123 |
| PPB | 0.830953 |
| VDSS | 0.699 |
| FU | 0.146932 |
| CYP1A2-inh | 0.045 |
| CYP1A2-sub | 0.965 |
| CYP2c19-inh | 0.109 |
| CYP2c19-sub | 0.979 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.831 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.956 |
| CYP3a4-inh | 0.314 |
| CYP3a4-sub | 0.963 |
| CL | 8.921 |
| T12 | 0.093 |
| hERG | 0.986 |
| Ames | 0.08 |
| ROA | 0.378 |
| SkinSen | 0.82 |
| Carcinogencity | 0.046 |
| EI | 0.003 |
| Respiratory | 0.571 |
| NR-Aromatase | 0.173 |
| Antiviral | No |
| Prediction | 0.717049 |